# MariTide bioavailability study record updated

> ClinicalTrials.gov lists a completed Maridebart cafraglutide study sponsored by Amgen.

- Evidence object: `story:maritide-bioavailability-study-updated:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-07-21
- Source checked: 2026-07-22
- Published by PeptideScanner: 2026-07-22
- Story landing page: https://peptidescanner.com/stories/maritide-bioavailability-study-updated/
- JSON record: https://peptidescanner.com/evidence/v1/objects/maritide-bioavailability-study-updated-v1.json
- Content SHA-256: `8740f061c009edfa52bba994d01c65bb199b0fa86834adc7a956e07c519c26e9`

## Claims and source pins

### Headline

MariTide bioavailability study record updated ([`ctg-nct07717814-v1`](#source-ctg-nct07717814-v1))

### Summary

ClinicalTrials.gov lists a completed Maridebart cafraglutide study sponsored by Amgen. ([`ctg-nct07717814-v1`](#source-ctg-nct07717814-v1))

### Paragraph 1

ClinicalTrials.gov lists the NCT07717814 record under Amgen. Its overall recruitment status was shown as completed when PeptideScanner reviewed the record. ([`ctg-nct07717814-v1`](#source-ctg-nct07717814-v1))

### Paragraph 2

The registry shows 2026-07-21 as its latest posted update date. This update reports the registry record and does not establish safety, effectiveness, or a trial outcome. ([`ctg-nct07717814-v1`](#source-ctg-nct07717814-v1))

## Sources

<a id="source-ctg-nct07717814-v1"></a>
- **Bioavailability of AMG 133 in Participants With Overweight or Obesity · record history version 1 · last update posted 2026-07-21** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07717814?a=1&tab=history) (`ctg-nct07717814-v1`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "MariTide bioavailability study record updated." Version 1, published 2026-07-22. https://peptidescanner.com/evidence/v1/objects/maritide-bioavailability-study-updated-v1.json SHA-256: 8740f061c009edfa52bba994d01c65bb199b0fa86834adc7a956e07c519c26e9.